Todd Griffin, MD, MBA
Sanguinity Foundation Endowed Chair in Women’s Health
Department of Obstetrics, Gynecology and Reproductive Medicine
Todd Griffin was raised in Sayville on Long Island. He completed his undergraduate studies at the University of Rochester before returning to Long Island to earn his medical degree and complete his residency, in obstetrics and gynecology, from the Renaissance School of Medicine and Stony Brook University Hospital. Dr. Griffin then served as a lieutenant commander in the U.S. Navy for three years before returning to Stony Brook in 2000.
Dr. Griffin specializes in minimally invasive and robotic gynecologic surgery and was instrumental in the development of robotic surgery at Stony Brook Medicine, completing the first gynecologic robotic surgery on Long Island. Dr. Griffin is a professor of obstetrics and gynecology and currently serves as the Vice Dean for Clinical Affairs and Vice President for Clinical Services. His previous institutional roles include Chair of Obstetrics and Gynecology from 2012 to 2023, and Chief Medical Officer of Stony Brook University Hospital from 2009 to 2013. He has also served as Medical Board President, Chair of the Faculty Practice Plan as well as residency program director, clerkship director and fellowship director for minimally invasive gynecologic surgery fellowship program.
A few of his honors include the Aesculapius Award, which is the Renaissance School of Medicine’s highest teaching award and the Chancellor’s Award for Excellence in Faculty Service. He served as an oral board examiner for the American Board of Obstetrics and Gynecology for 15 years and is an emeritus executive board member of the Council of Chairs of Obstetrics and Gynecology and the Society of Academic Specialists in General Obstetrics and Gynecology.
Dr. Griffin is the Sanguinity Foundation Endowed Chair in Women’s Health. Through the same foundation he received a $1.5 million philanthropic grant in 2022 to develop a polycystic ovary syndrome (PCOS) center – now renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to capture the complexity of this disorder. This multidisciplinary center has treated more than 1,500 new patients to Stony Brook Medicine and has led to seven clinical research trials.
